ID

4503

Descrizione

ACNS1123 Eligibility Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

collegamento

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Keywords

versioni (2)
  1. 09/12/13 09/12/13 - Martin Dugas
  2. 02/06/15 02/06/15 -
Caricato su

9 dicembre 2013

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0 Legacy
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

ACNS1123 Eligibility - 3377519v1.0

Inglese

No Instruction available.

1 moduli  
  1. StudyEvent: SE.0000
    1. No Instruction available.
Stratification
Descrizione

Stratification

ACNS1123 Stratum
Descrizione

ClinicalStudyACNS1123StratificationFactorsType

Tipo di dati

text

Study Treatment
Descrizione

TreatmentAssignmentType

Tipo di dati

text

Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
Descrizione

TreatmentBeginDate

Tipo di dati

date

Elig - Block 1
Descrizione

Elig - Block 1

Is the patient enrolled on the ALTE07C1 study?
Descrizione

OtherStudyEnrollmentInd-2

Tipo di dati

text

Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
Descrizione

PatientAgeEligibilityDeterminationInd-2

Tipo di dati

text

Was definitive diagnostic surgery performed?
Descrizione

FirstDiagnosisFromSurgicalProcedureIndicator

Tipo di dati

text

Date of definitive diagnostic surgery or clinical diagnosis:
Descrizione

PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate

Tipo di dati

date

Was lumbar CSF cytology obtained?
Descrizione

CerebrospinalFluidCellInd-3

Tipo di dati

text

Was it medically contraindicated? (If no,)
Descrizione

CerebrospinalFluidDiagnosticProcedureCytologyContraindicatedInd-2

Tipo di dati

text

Was lumbar CSF cytology negative?
Descrizione

LaboratoryProcedureLumbarPunctureCerebrospinalFluidNegativeFindingOutcomeInd-2

Tipo di dati

text

Elig - Block 2
Descrizione

Elig - Block 2

Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
Descrizione

GermCellTumorHistologicClassificationDiagnosisInd-2

Tipo di dati

text

Elig - Block 3
Descrizione

Elig - Block 3

Does patient have newly diagnosed localized primary CNS NGGCT?
Descrizione

NewPrimaryMalignantNeoplasmCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo di dati

text

Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
Descrizione

PathologyFindingsIndicator

Tipo di dati

text

Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
Descrizione

PatientProtocolRequirementEligibilityDeterminationInd-2

Tipo di dati

text

Elig - Block 4
Descrizione

Elig - Block 4

Does patient have newly diagnosed localized primary CNS germinoma?
Descrizione

NewChildhoodBrainGerminomaDiagnosisInd-2

Tipo di dati

text

Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
Descrizione

PatientProtocolRequirementEligibilityDeterminationInd-2

Tipo di dati

text

Elig - Block 5
Descrizione

Elig - Block 5

Peripheral absolute neutrophil count (ANC) (number/uL)
Descrizione

LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue

Tipo di dati

double

Unità di misura
  • ul
ul
Platelet count (number/uL): (Transfusion Independent)
Descrizione

LaboratoryProcedurePlateletResultSpecifiedValue

Tipo di dati

double

Unità di misura
  • 1000/uL
1000/uL
Hemoglobin(g/dL) (May receive RBC transfusion)
Descrizione

LaboratoryProcedureHemoglobinResultSpecifiedValue

Tipo di dati

double

Unità di misura
  • g/dL
g/dL
Elig - Block 5
Descrizione

Elig - Block 5

Creatinine clearance (mL/min/1.73m²):
Descrizione

LaboratoryProcedureCreatinineClearanceOutcomeValue

Tipo di dati

double

Radioisotope GFR(mL/min/1.73 m²)
Descrizione

LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue

Tipo di dati

double

Unità di misura
  • mL/Min/1.73m2
mL/Min/1.73m2
Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
Descrizione

LaboratoryProcedureCreatinineResultSpecifiedValue

Tipo di dati

double

Unità di misura
  • mg/dL
mg/dL
Elig - Block 7
Descrizione

Elig - Block 7

Total bilirubin (mg/dl), ULN
Descrizione

LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue

Tipo di dati

double

Unità di misura
  • mg/dL
mg/dL
Total bilirubin Value (mg/dl):
Descrizione

LaboratoryProcedureTotalBilirubinResultValue

Tipo di dati

double

Unità di misura
  • mg/dL
mg/dL
SGPT (ALT) or SGOT (AST) U/L, ULN:
Descrizione

LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue

Tipo di dati

double

SGPT (ALT) or SGOT (AST), U/L
Descrizione

LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue

Tipo di dati

double

Elig - Block 8
Descrizione

Elig - Block 8

Does patient have seizure disorder?
Descrizione

PatientSeizureDiseaseorDisorderInd-3

Tipo di dati

text

Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
Descrizione

NeurologicalEvaluationSeizureSymptomInd-2

Tipo di dati

text

Is patient in status, coma or assisted ventilation at study entry?
Descrizione

PatientMechanicalVentilationUseInd-2

Tipo di dati

text

Elig - Block 9
Descrizione

Elig - Block 9

Does patient have mature teratoma with normal tumor markers?
Descrizione

PatientCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo di dati

text

Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
Descrizione

ExternalBrainVentricleCentralNervousSystemGermCellTumorDiagnosisInd-2

Tipo di dati

text

Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
Descrizione

MetastaticDiseaseorDisorderMagneticResonanceImagingCerebrospinalFluidDiagnosisInd-2

Tipo di dati

text

Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
Descrizione

SurgicalInterventionCorticosteroidAdministeredInd-2

Tipo di dati

text

Is patient post menarcheal?
Descrizione

PediatricEndocrineMensesOnsetInd-2

Tipo di dati

text

Was a pregnancy test performed?
Descrizione

PatientPregnancyTestIndicator

Tipo di dati

text

Is patient pregnant? (If yes above,)
Descrizione

PatientPregnancyInd-2

Tipo di dati

text

Is patient nursing?
Descrizione

PersonBreastFeedingExclusionCriteriaIndicator

Tipo di dati

text

Has patient agreed to stop breastfeeding? (If yes above,)
Descrizione

BreastFeedingStopAgreementInd-4

Tipo di dati

text

Has patient agreed to use an effective contraceptive method for the duration of the study participation?
Descrizione

ContraceptionAgreementInd

Tipo di dati

text

Elig - Block 10
Descrizione

Elig - Block 10

Date Informed Consent Signed
Descrizione

InformedConsentFormSignedDate

Tipo di dati

date

Have all institutional, FDA, and NCI requirements for human studies been met?
Descrizione

StudyCompleteRequirementsInd-2

Tipo di dati

text

Comments
Descrizione

ResearchCommentsText

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

No Instruction available.

1 moduli
  1. StudyEvent: SE.0000
    1. No Instruction available.
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Stratification
CL.1
Code List
ACNS1123 Stratum
CL Item
Stratum 1 - Nggct (Stratum 1 - NGGCT)
CL Item
Stratum 2 - Germinoma (Stratum 2 - Germinoma)
Item
Study Treatment
text
CL.2
Code List
Study Treatment
CL Item
Treatment 1: A,b,a,b,a,b (Treatment 1 A B A B A B)
CL Item
Treatment 2: A,a,a,a (Treatment 2 A A A A)
TreatmentBeginDate
Item
Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
date
Item Group
Elig - Block 1
Item
Is the patient enrolled on the ALTE07C1 study?
text
CL.3
Code List
Is the patient enrolled on the ALTE07C1 study?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
text
CL.4
Code List
Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Was definitive diagnostic surgery performed?
text
CL.5
Code List
Was definitive diagnostic surgery performed?
CL Item
Yes (Yes)
CL Item
No (No)
PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate
Item
Date of definitive diagnostic surgery or clinical diagnosis:
date
Item
Was lumbar CSF cytology obtained?
text
CL.6
Code List
Was lumbar CSF cytology obtained?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Was it medically contraindicated? (If no,)
text
CL.7
Code List
Was it medically contraindicated? (If no,)
CL Item
Yes (Yes)
CL Item
No (No)
CL.8
Code List
Was lumbar CSF cytology negative?
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 2
Item
Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
text
CL.9
Code List
Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 3
Item
Does patient have newly diagnosed localized primary CNS NGGCT?
text
CL.10
Code List
Does patient have newly diagnosed localized primary CNS NGGCT?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
text
CL.11
Code List
Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
CL Item
Yes (YES)
CL Item
No (NO)
Item
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
text
CL.14
Code List
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have newly diagnosed localized primary CNS germinoma?
text
CL.13
Code List
Does patient have newly diagnosed localized primary CNS germinoma?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
text
CL.14
Code List
Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
CL Item
Yes (Yes)
CL Item
No (No)
LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue
Item
Peripheral absolute neutrophil count (ANC) (number/uL)
double
LaboratoryProcedurePlateletResultSpecifiedValue
Item
Platelet count (number/uL): (Transfusion Independent)
double
LaboratoryProcedureHemoglobinResultSpecifiedValue
Item
Hemoglobin(g/dL) (May receive RBC transfusion)
double
LaboratoryProcedureCreatinineClearanceOutcomeValue
Item
Creatinine clearance (mL/min/1.73m²):
double
LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue
Item
Radioisotope GFR(mL/min/1.73 m²)
double
LaboratoryProcedureCreatinineResultSpecifiedValue
Item
Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
double
LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue
Item
Total bilirubin (mg/dl), ULN
double
LaboratoryProcedureTotalBilirubinResultValue
Item
Total bilirubin Value (mg/dl):
double
LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue
Item
SGPT (ALT) or SGOT (AST) U/L, ULN:
double
LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue
Item
SGPT (ALT) or SGOT (AST), U/L
double
Item Group
Elig - Block 8
Item
Does patient have seizure disorder?
text
CL.15
Code List
Does patient have seizure disorder?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
text
CL.16
Code List
Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient in status, coma or assisted ventilation at study entry?
text
CL.17
Code List
Is patient in status, coma or assisted ventilation at study entry?
CL Item
Yes (Yes)
CL Item
No (No)
Item Group
Elig - Block 9
Item
Does patient have mature teratoma with normal tumor markers?
text
CL.18
Code List
Does patient have mature teratoma with normal tumor markers?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
text
CL.19
Code List
Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
text
CL.20
Code List
Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
text
CL.21
Code List
Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient post menarcheal?
text
CL.22
Code List
Is patient post menarcheal?
CL Item
Yes (yes)
CL Item
No (no)
Item
Was a pregnancy test performed?
text
CL.23
Code List
Was a pregnancy test performed?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Is patient pregnant? (If yes above,)
text
CL.24
Code List
Is patient pregnant? (If yes above,)
CL Item
Yes (Yes)
CL Item
No (No)
CL.25
Code List
Is patient nursing?
CL Item
Yes (Yes)
CL Item
No (No)
Item
Has patient agreed to stop breastfeeding? (If yes above,)
text
CL.26
Code List
Has patient agreed to stop breastfeeding? (If yes above,)
CL Item
Yes (Yes)
CL Item
No (No)
Item
Has patient agreed to use an effective contraceptive method for the duration of the study participation?
text
CL.27
Code List
Has patient agreed to use an effective contraceptive method for the duration of the study participation?
CL Item
Yes (Yes)
CL Item
No (No)
CL Item
N/a, Patient Is Not Of Reproductive Potential (NA patient is not of reproductive potential)
Item Group
Elig - Block 10
InformedConsentFormSignedDate
Item
Date Informed Consent Signed
date
Item
Have all institutional, FDA, and NCI requirements for human studies been met?
text
CL.28
Code List
Have all institutional, FDA, and NCI requirements for human studies been met?
CL Item
Yes (Yes)
CL Item
No (No)
ResearchCommentsText
Item
Comments
text
Ritorna all'inizio della pagina 

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial